You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 326 to 350 of about 5940
Next 25
07/26/2023
United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma
07/23/2023
Share Your Experiences With Glioblastoma Multiforme (GBM)
07/19/2023
Jill Biden welcomes proposal for Medicare to pay for navigation services for cancer patients
07/18/2023
NOX-A12 Plus Radiotherapy and Bevacizumab Produces Responses in Previously Untreated Glioblastoma
Announcement: Webinar tonight (Tuesday 7/18/23) on SurVaxM Vaccine for Brain Tumor Treatment
Manmeet Ahluwalia: ‘I Wanted to Come to the United States and Cure Cancer’
HighField Biopharmaceuticals Announces First Patient Dosed in Phase 1b/2 Trial of HF1K16 for Recurrent and Refractory Glioma
07/14/2023
Rare Brain Tumor Responds to Targeted Tumor Treatment with ‘Unprecedented’ Success
07/12/2023
Announcement: Webinar on SurVaxM Vaccine for Brain Tumor Treatment
Life expectancy in glioblastoma patients who had undergone stereotactic biopsy: a retrospective single-center study
Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence
07/10/2023
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
07/06/2023
PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
IL4R-Targeting Toxin MDNA55 Yields Promising OS in Recurrent Glioblastoma
Time has come (again!) to rally for the Promising Pathway Act!
Beating Brain Cancers With Sound Waves?
Time has come to rally for the Promising Pathway Act!
07/04/2023
Ancient Virus Awakening: Hidden Culprit in Glioblastoma Brain Cancer Aggressiveness
Copay Assistance Program is now open!
07/01/2023
Plus Therapeutics Releases Early-Cut Data From Cancer Studies For Brain Cancer Settings
06/30/2023
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
06/29/2023
Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers
06/22/2023
1000 Patients Treated With GammaTile Therapy
06/21/2023
xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research